欧洲 · 新闻 · Reuters
Gate Bioscience expands Lilly drug discovery deal worth more than $870 million
Gate Bioscience said on Monday it expanded a research and licensing agreement with Eli Lilly to develop treatments targeting disease-causing proteins, in a deal potentially…
在 Reuters 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.reuters.com)
